1. Home
  2. PSN vs HALO Comparison

PSN vs HALO Comparison

Compare PSN & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSN
  • HALO
  • Stock Information
  • Founded
  • PSN 1944
  • HALO 1998
  • Country
  • PSN United States
  • HALO United States
  • Employees
  • PSN N/A
  • HALO N/A
  • Industry
  • PSN EDP Services
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PSN Technology
  • HALO Health Care
  • Exchange
  • PSN Nasdaq
  • HALO Nasdaq
  • Market Cap
  • PSN 7.8B
  • HALO 7.3B
  • IPO Year
  • PSN 2019
  • HALO N/A
  • Fundamental
  • Price
  • PSN $59.40
  • HALO $57.75
  • Analyst Decision
  • PSN Strong Buy
  • HALO Buy
  • Analyst Count
  • PSN 12
  • HALO 9
  • Target Price
  • PSN $97.50
  • HALO $62.78
  • AVG Volume (30 Days)
  • PSN 1.8M
  • HALO 1.1M
  • Earning Date
  • PSN 02-19-2025
  • HALO 02-18-2025
  • Dividend Yield
  • PSN N/A
  • HALO N/A
  • EPS Growth
  • PSN 49.38
  • HALO 63.33
  • EPS
  • PSN 2.12
  • HALO 3.43
  • Revenue
  • PSN $6,750,576,000.00
  • HALO $1,015,324,000.00
  • Revenue This Year
  • PSN $25.71
  • HALO $23.48
  • Revenue Next Year
  • PSN $8.83
  • HALO $18.16
  • P/E Ratio
  • PSN $28.04
  • HALO $16.84
  • Revenue Growth
  • PSN 24.03
  • HALO 22.44
  • 52 Week Low
  • PSN $57.86
  • HALO $37.73
  • 52 Week High
  • PSN $114.68
  • HALO $65.53
  • Technical
  • Relative Strength Index (RSI)
  • PSN 10.86
  • HALO 62.93
  • Support Level
  • PSN $72.12
  • HALO $56.07
  • Resistance Level
  • PSN $76.21
  • HALO $60.67
  • Average True Range (ATR)
  • PSN 2.60
  • HALO 1.43
  • MACD
  • PSN -1.36
  • HALO -0.22
  • Stochastic Oscillator
  • PSN 7.17
  • HALO 48.86

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: